Shanghai Junshi Biosciences Co., Ltd. (HKG:1877)
Hong Kong · Delayed Price · Currency is HKD 18.19
-0.39 (-2.10%)
Jul 30, 2026, 3:40 PM HKT
HKG:1877 Market Cap
HKG:1877 has a market cap or net worth of 36.8 billion as of July 29, 2026. Its market cap has decreased by -8.78% in one year.
Market Cap
36.80B
Enterprise Value
38.63B
Revenue
3.10B
Ranking
n/a
PE Ratio
n/a
Stock Price
18.19
ChartMarket Cap Chart
Since December 24, 2018, HKG:1877's market cap has increased from 18.06B to 36.80B, an increase of 103.78%. That is a compound annual growth rate of 9.82%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 29, 2026 | 36.80B | 6.17% |
| Dec 31, 2025 | 34.66B | 39.72% |
| Dec 31, 2024 | 24.81B | -37.28% |
| Dec 29, 2023 | 39.55B | -38.85% |
| Dec 30, 2022 | 64.67B | -7.04% |
| Dec 31, 2021 | 69.57B | -9.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 24, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sino Biopharmaceutical | 93.12B |
| Akeso | 88.11B |
| RemeGen | 65.64B |
| Biocytogen Pharmaceuticals (Beijing) | 49.57B |
| 3SBio | 43.56B |
| Genscript Biotech | 38.08B |
| Shanghai Henlius Biotech | 28.94B |
| InnoCare Pharma | 28.50B |